Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2026-07-30 16:13:47 ET · period of report 2026-07-28 · accession 0001193125-26-326144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-30 16:13 | 2026-07-28 | RLAY | Catinazzo Thomas | CFO | S - Sale | $18.61 | -1,459 | 158.3K | -0.9% | -$27.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-28 | S | D | 1,459 | $18.61 | 158,285 | D | — | — | (F1) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 3,269 shares of restricted stock units ("RSUs") on July 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F2) Includes 6,538 shares underlying RSUs. |